- Home
- ADXN vs ADIL Comparison
ADXN vs ADIL Comparison
Compare ADXN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- ADIL
- Stock Information
- Founded
- ADXN 2002
- ADIL 2010
- Country
- ADXN Switzerland
- ADIL United States
- Employees
- ADXN N/A
- ADIL N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- ADIL Health Care
- Exchange
- ADXN Nasdaq
- ADIL Nasdaq
- Market Cap
- ADXN 8.0M
- ADIL 6.5M
- IPO Year
- ADXN N/A
- ADIL 2018
- Fundamental
- Price
- ADXN $7.97
- ADIL $0.96
- Analyst Decision
- ADXN Strong Buy
- ADIL Strong Buy
- Analyst Count
- ADXN 1
- ADIL 1
- Target Price
- ADXN $30.00
- ADIL $8.00
- AVG Volume (30 Days)
- ADXN 25.1K
- ADIL 86.8K
- Earning Date
- ADXN 11-22-2024
- ADIL 11-13-2024
- Dividend Yield
- ADXN N/A
- ADIL N/A
- EPS Growth
- ADXN N/A
- ADIL N/A
- EPS
- ADXN 0.06
- ADIL N/A
- Revenue
- ADXN $701,260.00
- ADIL N/A
- Revenue This Year
- ADXN N/A
- ADIL N/A
- Revenue Next Year
- ADXN N/A
- ADIL N/A
- P/E Ratio
- ADXN $1.03
- ADIL N/A
- Revenue Growth
- ADXN N/A
- ADIL N/A
- 52 Week Low
- ADXN $6.45
- ADIL $0.77
- 52 Week High
- ADXN $27.90
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- ADXN 50.40
- ADIL 37.57
- Support Level
- ADXN $7.28
- ADIL $0.99
- Resistance Level
- ADXN $8.36
- ADIL $1.06
- Average True Range (ATR)
- ADXN 0.74
- ADIL 0.06
- MACD
- ADXN 0.05
- ADIL -0.01
- Stochastic Oscillator
- ADXN 50.26
- ADIL 0.00
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.